Differential Expression of Potential Biomarkers of Oral Squamous Cell Carcinoma Development
Authors:
- Paola Fernandes PansiniPPPaola Fernandes Pansini
- Isabella Bittencourt Do ValleIVIsabella Bittencourt Do Valle
- Thabata Coeli Dias DamascenoTDThabata Coeli Dias Damasceno
- Priscila Marinho de AbreuPAPriscila Marinho de Abreu
- Anna Clara Gregório CóACAnna Clara Gregório Có
- Rossana Verónica Mendoza LópezRLRossana Verónica Mendoza López
- Jeferson LenziJLJeferson Lenzi
- Ricardo Mai RochaRRRicardo Mai Rocha
- Evandro Duccini SouzaESEvandro Duccini Souza
- Maria Paula CuradoMCMaria Paula Curado
- Hisham MehannaHMHisham Mehanna
- Paul NankivellPaul Nankivell
- 11 April 2021
- journal article
- research article
- Published by Springer Nature in Head and Neck Pathology
- Vol. 15 (4) , 1127-1136
Abstract
To evaluate molecular epithelial changes, we investigated whether a profile of survivin, cyclin dependent kinase inhibitor 2A (CDKN2A), epidermal growth factor receptor (EGFR), polo like kinase 1 (PLK1), p63, p40 (Δnp63 isoform), cyclin D1 (CCND1) and BCL2 apoptosis regulator (BCL2) proteins could predict malignant transformation. Different tissue segments (tumor adjacent epithelium; dysplasia and tumor) from a total of 109 patients were analyzed by immunohistochemistry. An increased expression of survivin (p < 0.001), PLK1 (p = 0.001), and p63 (p < 0.001) in parallel to reduced immunostaining of p40 (p < 0.001) and BCL2 (p = 0.029) was observed among the tissue segments analyzed. Our study revealed that survivin, PLK1, p63, p40 and BCL2 play a role in oral tumorigenesis and represent promising biomarkers able to recognize mesenchymal phenotype induction in the transition from nonmalignant cells to tumor cells. These results reveals critical interaction between survivin, PLK1, p63, p40 promising proteins during invasive carcinoma development.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação Estadual de Amparo à Pesquisa do Estado do Espírito Santo (FAPES/CNPq/Decit-SCTIE-MS/SESA – PPSUS, Protocol number 83139940/2018)
This publication has 35 references indexed in Scilit:
- Survivin and pAkt as potential prognostic markers in squamous cell carcinoma of the head and neckOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2014
- Overexpression of Survivin and Caspase 3 in Oral CarcinogenesisApplied Immunohistochemistry & Molecular Morphology, 2014
- Possible involvement of ΔNp63 downregulation in the invasion and metastasis of oral squamous cell carcinoma via induction of a mesenchymal phenotypeClinical & Experimental Metastasis, 2013
- Epithelial to mesenchymal transition (EMT) biomarkers – E-cadherin, beta-catenin, APC and Vimentin – in oral squamous cell carcinogenesis and transformationOral Oncology, 2012
- Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinomaInternational Journal of Oncology, 2011
- Role of p63 in cancer developmentBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2011
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNMAnnals of Surgical Oncology, 2010
- Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformationOral Oncology, 2006
- Validating survivin as a cancer therapeutic targetNature Reviews Cancer, 2003
- Decreased expression of bcl-2 in moderate and severe oral epithelia dysplasiasOral Oncology, 2002